MentionFox
Home › funding signals › Contraline, Inc.
Form D · on the record

Contraline — $55.80M Form D filing, June 2026

Contraline, Inc. filed a Form D with the Securities and Exchange Commission on 2026-06-10.

Announced $92.5M on 2026-06-02; Form D shows $55.8M sold as of 2026-06-10. Announced vs filed

Contraline, Inc. filed a Form D notice of an exempt securities offering with the SEC on June 10, 2026. The filing reports $55.80M sold. Its industry group is Biotechnology. It names Kevin Eisenfrats (Executive Officer, Director, Promoter), Martin Emerson (Director), Gurdane Bhutani (Director) (SEC Form D, June 10, 2026).

125 companies raised this week.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

Andersen Aggregator LLC$1.9BBusiness services
AT Umbrella LLC$1.9BBusiness services
Legora, Inc.$221MAI and software
MD INVESTMENT LLC$169MBusiness services
Serval Inc.$149MAI and software
Check one company free

3 more Biotechnology raises in Virginia within 90 days ↓

Is this your company?

Key facts

Run the free check on Contraline, Inc. →

Sell to companies like Contraline, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Contraline, Inc.

New Form D on file · 2026-06-10 · the record

$55.80M
raise on the record
D
filing
77
investors in
VIRGINIA
based
Open the record →

What the record says

FilingForm D
Filed2026-06-10
Industry groupBiotechnology
Entity typeCorporation
Incorporated inDELAWARE
BasedCHARLOTTESVILLE, VIRGINIA
CIK1818752
Accession0001818752-26-000003

Pitching, partnering or investing alongside them? See who really runs and owns Contraline, Inc.

Free to see. No signup.

Keep reading

More on the people and the money behind Contraline, Inc., from the filings we hold.

More raises like this

Biotechnology raises by companies based in Virginia, filed within 90 days of this one, largest first.

What do you want to do with Contraline, Inc.?

Get the full cited report on Contraline, Inc.

What the filing shows about Contraline, Inc.

  • The filing shows $55.8M sold; the announcement on 2026-06-02 said $92.5M.
  • 77 investors had already put money in when it filed.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Contraline, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Who the filing names, and in what role

The filing gives Contraline, Inc.'s address as 818 E. Jefferson St Suite 201, Charlottesville, VA 22902.

What the filing says

  • Offered: $115,929,658. Sold: $55,804,741. Left to sell: $60,124,917. (filing)
  • Investors: 77 had already invested. (filing)
  • Date of first sale: May 29, 2026. (filing)
  • Types of securities: Equity. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)
  • Securities that converted: the filing says “Includes shares of preferred stock issued pursuant to the cancellation of SAFE indebtedness in the amount of $23,429,880.” (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Contraline, Inc. See pricing

Is Contraline, Inc. a real, registered company?

Contraline, Inc. is a registered filer with the SEC (CIK 1818752) and has filed since 2026-06-10. 1 filing is on record, the latest on 2026-06-10.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Contraline, Inc.?

Contraline, Inc.'s Form D of 2026-06-10 names Kevin Eisenfrats, Martin Emerson, Gurdane Bhutani and 1 more as its officers, directors or promoters.

How much has Contraline, Inc. raised?

Its new offerings report $55.80M sold across 1 offering, as its own filings state.

Biotechnology · by week
This raise, $55.80M, filed week of Jun 8

Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $55.80M, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on Contraline, Inc.?

What the filing shows about Contraline, Inc.

  • The filing shows $55.8M sold; the announcement on 2026-06-02 said $92.5M.
  • 77 investors had already put money in when it filed.
  • The filing names 4 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Contraline, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Contraline, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    4 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Contraline, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-09-26 (contraline.com).

RSS

Tools for this story

Each opens in a new tab, filled in for Contraline, Inc.. With no account yet, you sign up free and land on the result.

On these startup lists

Healthcare and health tech startups Biotech startups

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Contraline, Inc.: Raised $55.80M, Form D filed 2026-06-10
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/contraline-inc-form-d-26000001
Last updated 2026-10-20
Primary record: SEC filing 1 · SEC filing 2
Contraline raised $55.80M — SEC Form D filing, June 2026. MentionFox, 2026-10-20. https://mentionfox.com/funding/contraline-inc-form-d-26000001